Mukesh Harisinghani, MD

Mukesh Harisinghani, MD, Director of the Clinical Discovery Program Center for Molecular Imaging Research at the Massachusetts General Hospital, reviews recent research on the effectiveness of MRI-targeted biopsy as well as systematic biopsy on biopsy naive patients. Through the analysis of research results, he reveals that there is consistent evidence to support that combining the two techniques creates a substantial boost in detection rates. This boost has been proven to be a shift from a 21.4% detection rate in just systematic biopsy and 23.4% in just MRI-targeted biopsy to a detection rate of 27.7% when using combined techniques on biopsy naive patients.